Product Manager, Denmark and Sweden – Coagulation

LEO Pharma seeks a passionate Product Manager to strengthen the successful coagulation team. This is your opportunity to join an independent research based pharmaceutical company and work with a strategic product within the LEO Pharma portfolio. The Danish/Swedish affiliate of LEO Pharma is situated in Malmö. You will have a central role in our Business Unit and report to the Business Unit Manager.

 

Field of responsibilities

  • Development of marketing plans and materials
  • Forecasts and budgets
  • Contact with advertising- and PR agencies
  • Contact with key customers
  • Responsibility for our participation in national and international meetings

 

Your qualifications

  • You have a Master’s degree in natural science and/or commerce, and at least 3 years of profound experience within the pharmaceutical industry preferably within hospital sales. Experience in the Danish and Swedish markets and knowledge from tender business will be favoured. You are fluent in written and spoken English.
  • On a professional level, you have profound commercial and strategic knowledge and understanding, project management experience as well as excellent communication and presentation skills. You are analytic and organised, meet deadlines and high quality demands in a dynamic environment. You are flexible also with respect to travelling.
  • On a personal level, you have a strong business mindset, are self-driven, proactive and dynamic as well as a strong team player.

LEO offers

  • A career opportunity in a growing, global pharmaceutical company plus an attractive salary and benefit package as well as continued professional and personal development.

Any questions regarding the position can be answered by Business Unit Manager Niklas Eriksson, phone +46 703 33 76 74. You may also contact our HR Consultant Jörgen Telg, phone +46 708 70 63 28.

If you find the above position attractive, please send your application marked with the respective position to monica.nilsson@leo-pharma.com not later than 23 February, 2011.